Fundz

Precision Biosciences Inc reported raising $88.1 Million in an initial SEC Form D filing, from an offering of $110 Million

PUBLIC · DTILJun 08, 2018$88.1M of $110M raised

Amount Raised

$88.1 Million

$88.1 Million sold, per SEC Form D (first sale Jun 8, 2018)

Round Type

Venture

DurhamBiotechnologyHealth CareGeneticsTherapeutics

Who to call at Precision BioSciences, and when

A new round usually means Precision BioSciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Precision BioSciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Precision BioSciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Precision BioSciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Precision BioSciences

Location

302 EAST PETTIGREW STREET

Durham, North Carolina, United States

About

Precision is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure. Key capabilities and differentiating characteristics may enable ARCUS nucleases to drive more intended, defined therapeutic outcomes. Using ARCUS, Precision’s pipeline is comprised of in vivo gene editing candidates designed to deliver lasting cures for the broadest range of genetic and infectious diseases where no adequate treatments exist.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Precision BioSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

5 contacts
Verified contactsNaresh T., Chief of Staff to the CEO / Commercial… hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Precision BioSciences's next move

See what Strategic adds

Precision BioSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.